These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 987942

  • 21. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
    Hardt W, Schmidt-Gollwitzer K, Nevinny-Stickel J, Schmidt-Gollwitzer M.
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
    [Abstract] [Full Text] [Related]

  • 22. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S, Charbonnel B, Massai MR, Marraoui J, Spitz I, Bouchard P.
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [Abstract] [Full Text] [Related]

  • 23. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 24. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec 15; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 25. [Preclinical research and development of norethisterone].
    Mcguire JL, Hahn DW, Philipps A.
    Contracept Fertil Sex (Paris); 1985 Jan 15; 13(1 Suppl):437-44. PubMed ID: 12280212
    [Abstract] [Full Text] [Related]

  • 26. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill.
    Cohen J, Debache C, Solal P, Serkine AM, Achard B, Boujenah A, Pez JP, Paris X, Robert J, Loffredo V.
    Hum Reprod; 1987 Jan 15; 2(1):7-9. PubMed ID: 3106405
    [Abstract] [Full Text] [Related]

  • 27. Comparison of serum progesterone and endometrial biopsy for confirmation of ovulation and evaluation of luteal function.
    Shepard MK, Senturia YD.
    Fertil Steril; 1977 May 15; 28(5):541-8. PubMed ID: 856637
    [Abstract] [Full Text] [Related]

  • 28. Assessment of possible luteolytic effect on intra-ovarian injection of prostaglandin F-2ALPHA in the human.
    Korda AR, Shutt DA, Smith ID, Shearman RP, Lyneham RC.
    Prostaglandins; 1975 Mar 15; 9(3):443-9. PubMed ID: 1138301
    [Abstract] [Full Text] [Related]

  • 29. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G, George M, Lestrat N, Reinberg A, Baulieu EE.
    J Clin Endocrinol Metab; 1985 Sep 15; 61(3):484-9. PubMed ID: 2991322
    [Abstract] [Full Text] [Related]

  • 30. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin.
    Cameron IT, Baird DT.
    Acta Endocrinol (Copenh); 1988 Jun 15; 118(2):161-7. PubMed ID: 3291533
    [Abstract] [Full Text] [Related]

  • 31. The effect of various steroids on corpus luteum function.
    Hooley RD, Williams DM, Findlay JK.
    Contraception; 1977 Jan 15; 15(1):53-64. PubMed ID: 880803
    [Abstract] [Full Text] [Related]

  • 32. [Luteolytic agents and reproduction].
    Cortés-Gallegos V.
    Gac Med Mex; 1973 Oct 15; 106(4):259-86. PubMed ID: 4593968
    [No Abstract] [Full Text] [Related]

  • 33. Response to intermittent RU486 in women.
    Spitz IM, Croxatto HB, Salvatierra AM, Heikinheimo O.
    Fertil Steril; 1993 May 15; 59(5):971-5. PubMed ID: 8486197
    [Abstract] [Full Text] [Related]

  • 34. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1992 Oct 15; 58(4):680-4. PubMed ID: 1426309
    [Abstract] [Full Text] [Related]

  • 35. Presence of corpus luteum as evidence of ovulation in women treated with low doses of chlormadinone acetate.
    Gutiérrez-Nájar A, Márquez-Monter H, Giner-Velázquez J, Martínez-Manautou J.
    Am J Obstet Gynecol; 1968 Dec 01; 102(7):1018-22. PubMed ID: 4177692
    [Abstract] [Full Text] [Related]

  • 36. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE, Doose DR, Walker SA, Nayak RK.
    Epilepsia; 1997 Mar 01; 38(3):317-23. PubMed ID: 9070594
    [Abstract] [Full Text] [Related]

  • 37. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM, Segal S, Salem HT, Ghaneimah SA, Khalifa EA, Ahmed AG.
    Fertil Steril; 1993 May 01; 59(5):998-1002. PubMed ID: 8486202
    [Abstract] [Full Text] [Related]

  • 38. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Contracept Deliv Syst; 1983 Apr 01; 4(2):107-25. PubMed ID: 12338631
    [Abstract] [Full Text] [Related]

  • 39. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar 01; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 40. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM, Thompson IE, Taymor ML.
    Acta Endocrinol (Copenh); 1975 Aug 01; 79(4):625-34. PubMed ID: 1098349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.